• Phalloidin (B7678): Technical Guide for F-Actin Stabilizatio

  2026-08-04

  Phalloidin (SKU B7678) addresses the need for reliable, high-affinity stabilization and visualization of filamentous actin (F-actin) in fixed or permeabilized samples. It is not suitable for live-cell imaging or for studies requiring reversible actin binding. Researchers should use this reagent for static cytoskeleton analysis where precise preservation of actin architecture is critical.

• Pronase E (≥7000 U/g): Precision Protease for Ubiquitin-Prot

  2026-08-04

  Explore how Pronase E, a potent protease mixture, empowers advanced protein sample preparation and mechanistic studies—especially in ubiquitin-proteasome pathway research. This article offers deeper scientific insights and practical guidance on leveraging Pronase E in complex molecular biology workflows.

• UBR5 Inhibition Stabilizes TERT and Preserves Vascular Funct

  2026-08-03

  Zhao et al. (2024) demonstrate that inhibiting the E3 ligase UBR5 stabilizes telomerase reverse transcriptase (TERT) and protects human vascular organoids from oxidative stress-induced damage. This work identifies a mechanism by which TERT stability can be therapeutically enhanced to support endothelial health and delay cellular senescence.

• PDHA1 Succinylation and α-Ketoglutarate in Cholangiocarcinom

  2026-08-03

  This study identifies PDHA1 lysine 83 succinylation as a driver of alpha-ketoglutarate accumulation in cholangiocarcinoma, which impairs macrophage antigen presentation and promotes immune escape. By mechanistically linking metabolic reprogramming to tumor immune evasion, the findings highlight PDHA1 succinylation as a promising therapeutic target for overcoming chemotherapy resistance.

• E-64d (SKU A1903): Precision Protease Inhibition in Cell Ass

  2026-08-02

  This article addresses real-world laboratory challenges in cell viability, apoptosis, and neuroprotection assays, demonstrating how E-64d (SKU A1903) delivers reproducible, data-backed cysteine protease inhibition. Through scenario-driven Q&A, we explore protocol optimization, data interpretation, and vendor reliability to help researchers select and implement E-64d effectively.

• Cell Adhesion Incompatibility: A Barrier to Interspecies Chi

  2026-08-01

  Ballard et al. reveal that mismatches in cell adhesion molecules form a significant barrier to generating interspecies chimeras using pluripotent stem cells from evolutionarily distant species. By engineering synthetic nanobody-antigen interactions, the study demonstrates a practical approach to enhancing cell integration and improving chimerism rates, with implications for organogenesis research and regenerative medicine.

• Tirbanibulin Suppresses HPV Oncoproteins and Cell Growth in

  2026-07-31

  This study demonstrates that tirbanibulin markedly inhibits proliferation of HPV-18–positive HeLa cells and downregulates a range of oncogenic proteins, including HPV E6/E7 and components of the Src-MEK signaling pathway. The work provides mechanistic insight into tirbanibulin's antiproliferative effects and suggests new research directions for HPV-associated malignancies.

• Tetrandrine Alkaloid: Mechanisms and Protocols for Ion Chann

  2026-07-31

  Tetrandrine is a potent, DMSO-soluble alkaloid that modulates calcium channels and is widely used in ion channel and cancer biology research. Its precise mechanism, rigorous storage requirements, and reproducible performance make it a benchmark tool for pharmacological and signaling pathway studies. This article synthesizes current evidence, clarifies application boundaries, and details validated protocol parameters.

• TLS-Mediated B Cell Activation in ESCC via CD40-STING-TRAF2-

  2026-07-30

  This study unveils how tertiary lymphoid structures (TLS) drive antitumor immunity in esophageal squamous cell carcinoma (ESCC) through competitive binding of CD40 and STING with TRAF2, leading to IRF4-mediated B cell activation. The findings provide mechanistic insight into TLS function, suggesting new biomarkers and therapeutic strategies for ESCC.

• SB-505124 Hydrochloride: Transforming Fibrosis and Cancer Re

  2026-07-30

  This thought-leadership article explores the mechanistic power and translational promise of SB-505124 hydrochloride, a selective TGF-β/activin pathway inhibitor. By dissecting its role in modulating cellular stiffness, fibrosis, and cancer metastasis, it offers actionable insights for researchers aiming to bridge molecular insights with clinical innovation, and sets a new benchmark for rigor and strategic foresight in the use of ALK inhibitors.

• Peptidisc-Assisted Nanobody Multimerization: Expanding Prote

  2026-07-29

  Chen and Duong van Hoa introduce a peptidisc-based method for assembling multimeric and multispecific nanobody complexes, termed polybodies. This strategy leverages hydrophobic clustering stabilized by peptidiscs, enhancing stability and functionality in nanobody engineering and offering a detergent-free alternative to existing multimerization approaches.

• PYR-41: Applied Workflows for Ubiquitin-Activating Enzyme E1

  2026-07-29

  PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect ubiquitin-proteasome system dynamics in real time. This guide details optimized workflows, advanced troubleshooting, and unique assay choices for translational inflammation and virology models.

• PF-573228: FAK Inhibitor Workflows for Mechanotransduction &

  2026-07-28

  PF-573228, a gold-standard FAK inhibitor from APExBIO, empowers researchers to dissect how substrate stiffness and cell adhesion cues drive signaling in cancer and tissue engineering. This guide covers actionable protocols, troubleshooting, and advanced applications, bridging recent mechanotransduction breakthroughs with robust experimental design.

• AMPK Suppresses Autophagy: Revisiting Energy Stress Response

  2026-07-28

  This study overturns the prevailing model by demonstrating that AMPK, rather than universally inducing autophagy, actively suppresses the autophagy-initiating kinase ULK1 during energy stress. These findings reshape our understanding of energy metabolism regulation and have significant implications for experimental approaches in metabolic and autophagy research.

• Nifedipine (BAY-a-1040) in Calcium Influx and Liver Regenera

  2026-07-27

  Nifedipine (BAY-a-1040) is a precision L-type calcium channel blocker enabling advanced studies of calcium-dependent signaling, iron metabolism, and fungal pathogenesis. This article unpacks stepwise experimental workflows, highlights protocol nuances, and contextualizes Nifedipine within the expanding landscape of liver regeneration and drug metabolism models.

16682 records 1/1113 page Next 12345 下5页 Last page